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Abstract 
Lumbar discectomy is considered a safe, efficacious and cost-effective treatment for 
selected cases of patients with leg pain associated with the presence of a disc 
protrusion, but despite technically successful surgery, 30% of patients complain of 
persistent pain on long-term follow up. Identification of possible predictors for a negative 
outcome is important, in the search for appropriate pre- and/or post-operative care and 
prevention of persistent disability. There is some evidence in the literature that 
quantitative sensory testing (QST) measures may play a role in prediction of patients’ 
pain persistency, however, this has never been investigated in patients undergoing 
lumbar discectomy. 
 
The aim of this study is to determine the predictive value of QST parameters, in 
combination with previously documented predictor variables such as 
medical/psychological/cognitive behavioural factors, in patients with lumbar 
radiculopathy and/or radicular pain, for predicting patients’ clinical outcome after lumbar 
discectomy.  
 
Participants with radiculopathy and/or radicular pain and confirmed imaging diagnosis of 
nerve root compression will be recruited from the elective surgery waitlist at one hospital. 
All participants will undergo lumbar discectomy performed by one neurosurgeon. A 
standardized QST protocol comprising all of the somatosensory sub-modalities that are 
mediated by different primary afferents (C-, Aδ-, Aβ-) will be performed prior to surgery. 
QST will be conducted in the patients’ main pain area and contralateral side, in the 
affected dermatome and at a remote control site. The presence of other predictor 
variables will be captured by questionnaires. Follow-up at 3 months will include QST and 
measurements of pain intensity, pain descriptors, functional status, health related quality 
of life, return to work and health care utilisation. A further 1-year follow-up will include the 
same measurements except QST.  
 
Identification of new predictor variables may assist in the development of pre-surgical 
screening methods and in targeted pre- and/or post-operative patient care, with the 
potential to improve patients’ functional status, quality of life, work capacity whilst also 
reducing health care costs associated with persistent disability. 
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Trial Registration: The Australian New Zealand Clinical Trials Registry (366797); Ethical 





Low back pain is one of the most common health problems and affects 80 – 85% of 
people over their life time [36]. Low back-related leg pain or sciatica, characterised by 
radiating pain that follows a dermatomal pattern [53],is a common variation of LBP. The 
prevalence of sciatic symptoms in the general population ranges from 1.2% to 43% in 
the literature [29]. Although the prognosis is good in most patients, up to 30% of patients 
continue to have pain for 1 year or longer [54; 56].  
 
Sciatia is most frequently caused by a nerve root compression due to disc herniation [54] 
and can be accompanied by signs of a nerve root lesion, such as neurological sensory 
or motor deficits. Patients with sciatica are likely to present with nociceptive as well as 
neuropathic pain (defined as ‘pain caused by a lesion or disease of the somatosensory 
nervous system’ [26]). Neuropathic pain has been shown to be associated with greater 
pain severity, increased suffering, increased disability, more impaired quality of life and 
greater health care costs than purely nociceptive low-back related leg pain [16; 43; 44; 
45].  
 
Lumbar discectomy is considered a cost-effective treatment for selected cases of 
patients with leg pain associated with the presence of a disc protrusion [19], but despite 
technically successful surgery, 30% of patients complain of persistent pain on long-term 
follow up [10] which is associated with substantial health care costs [38] and reduced 
work capacity [9].  
 
Numerous risk factors and predictors for a negative outcome of disc surgery have been 
identified [32], including pain history [34], diagnosis specific clinical features such as size 
of disc herniation, Lasègue sign [28], pre-surgical intake of medication and poor 
functional status [37], psychological and cognitive-behavioural factors such as fear 
avoidance behaviour and negative outcome expectancy [8; 9; 27], pain catastrophizing 
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[30], depression and anxiety [7; 13; 28]. However, it is not possible to identify an 
unequivocal predictor due to interactions between several risk factors, large variances in 
study designs, patient clinical profiles and used outcome measures [32]. 
 
An additional approach to explore predictive factors for pain persistency may lie in the 
investigation of sensory parameters, measured by quantitative sensory testing (QST). 
QST has been widely used to obtain reliable quantitative measures of large and small 
sensory nerve fibre dysfunction, manifesting as presence of sensory loss and/or 
enhanced pain sensitivity (hyperalgesia, allodynia) [22; 42; 47], a feature of central 
sensitisation and key mechanisms in the development and maintenance of persistent 
pain, in particular neuropathic pain [25]. Hence QST is a valuable tool to investigate 
clinical sensory phenotypes and to help interpret the pain mechanisms underlying 
associated clinical pain presentations.  
 
Several studies used QST for characterisation of post-operative pain [1; 2; 11; 20; 30; 
57; 58]. Heat pain thresholds predicted postoperative pain intensity three months after 
surgery in pain free patients undergoing surgical correction of thorax malformation, and 
cold and pressure pain thresholds predicted pain-related disability after 6 months in this 
cohort [30]. Furthermore, cold hyperalgesia measured in patients in the acute stage after 
sustaining a whiplash injury was a significant predictor of poor outcome at long-term 
follow up [49].  
 
QST data on patients with lumbar radiculopathy/sciatica are scarce. QST has been 
employed in this population in the affected dermatomal area to assess the function of 
sensory nerve fibers [17; 35; 59] and the recovery of nerve fiber function after lumbar 
decompression [33]. Preoperative loss of C-fibre function (measured by warm detection 
thresholds) was documented as negative predictive factor for lumbar microdiscectomy in 
39 patients undergoing surgical decompression[33]. However, no study to date has 
established the QST sensory profile of this patient cohort in relation to their main pain 
area, as is required for the assessment of neuropathic pain [21] and as proposed for the 
current study.  
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There is some evidence that some sensory fibre populations may be more effected by 
nerve root compression than others [17; 46] and that the difference in the extent of 
sensory fibre loss may account for variability of resulting symptoms such as sensory loss 
and/or enhanced pain sensitivity [24]. This may explain the identification of sub-groups 
of patients with differing sensory profiles, as observed in patients with cervical 
radiculopathy [52] and as documented in a large epidemiological study on 2094 patients 
with painful lumbar radiculopathy [31]. The identification of sub-groups in the latter study 
was based on pain descriptors of a neuropathic pain screening tool (painDETECT) [15]. 
 
It is postulated that differences in sensory profiles and underlying pain mechanisms may 
account for differences in responsiveness to pharmaceutical intervention targeting 
neuropathic pain associated with radiculopathy [3; 6; 43], and may account for 
differences in clinical outcome after discectomy. The proposed study will provide further 





The overall aim of this project is to determine the predictive value of somatosensory 
characteristics in participants with lumbar radiculopathy/radicular pain, for predicting 
participants’ clinical outcome after lumbar discectomy. Somatosensory characteristics 
will be explored using QST. Specific aims are: 
i. To establish the QST somatosensory profile of participants with lumbar 
radiculopathy/radicular pain before and after surgery  
ii. To investigate if there is an association between pre-surgical QST parameters 
and clinical outcome (functional status, pain intensity,health-related quality of life 
(HRQoL), return to work, confidence in recovery, health care utilisation, global 
perceived impression of change, bothersomeness) after lumbar microdiscectomy  
 
Hypotheses: 
1. There will be sub-groups of participants with differing somatosensory profiles 
before surgery. 
2. There will be a difference in QST profiles between participants with and without 
persistent pain after surgery. 
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3. Sensory profiles showing enhanced pain sensitivity will be associated with pain 




Research question: Is there an association between pre-surgical quantitative sensory 
testing parameters and clinical outcome after lumbar microdiscectomy?  
 
METHODS 
Study Design: Prospective longitudinal observational study 
 
Study population: Participants will be recruited from the elective neurosurgery waiting 
list for lumbar microsurgical discectomy at Sir Charles Gairdner Hospital. In order to 
optimize standardization of data collection, only participants whose surgery will be 
performed at Osborne Park Hospital will be selected for recruitment. In this way it is 
guaranteed that surgery will always be performed by the same neurosurgeon (Prof. 
Lind), minimising variability in surgical care. The time allocation for surgeries and follow-
up appointments is fixed, therefore controlling for any bias due to time differences of 
assessments between patients. Participants will be assessed in the week prior to 
surgery and in the morning prior to the follow-up appointment with the surgeon at 3 
months.  
 
Sample Size: Between 2010 and 2011 approximately 54 lumbar discectomies were 
performed at Osborne Park Hospital. The number of discectomies increased in 2012 to 
41 and in 2013 to 70. A sample of 70 participants is feasible for this study, considering 
the exclusion criteria, loss to follow up and the given time frame of the PI’s fellowship. 
 
The Oswestry Disability Index (ODI) will be used as primary outcome measure after 
surgery. The scoring of ODI is between 0-100 (100 maximum disability). 
10 points or 30% score improvement is the cut-off point for minimal important change 
[48]. A sample size of 40 participants is required to detect 10 units pre-post surgery with 
a power of 80% and 5% level of significance.   
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The inclusion criteria for the symptomatic participants will be as follows: age 18 to 65 
years; symptom duration of > 3 months; clinical diagnosis of lumbar radiculopathy 
(defined as conduction block along a spinal nerve or nerve root, manifesting clinically 
with dermatomal sensory loss or myotomal weakness or reflex changes [5]) and leg pain 
in L5 or S1 dermatomal distribution; demonstrable clinically relevant abnormality on 
imaging studies indicating nerve root compression at the relevant spinal level; person 
listed on the elective neurosurgery surgery waitlist for the procedure of lumbar 
discectomy. 
 
Exclusion criteria include diabetes and vascular disease (i.e. any disease affecting the 
vascular system and potentially affecting the sensation testing in any of the body regions 
to be assessed, e.g. Raynaud’s disease, peripheral arterial disease; other neurological 
or psychiatric disease; previous lumbar surgery; a history of any disorders that 
potentially might affect the sensation in the hand (negative control site) to be tested and 
an insufficient level of English to understand and fill out the questionnaires. Each 
participant must be able to understand the instructions/requirements for the quantitative 
sensory testing procedures and be able to give a reliable response that does not depend 
on translation and is not vulnerable to misinterpretation. 
 
Reference data from healthy control subjects (HC) will be obtained in order to compare if 
symptomatic participants differ from a healthy cohort. HCs will be matched for age and 
gender to the symptomatic participant groups and will be recruited from the local 
community. Subjects with a history of current pain or a chronic pain condition or any of 
the exclusion criteria described for the symptomatic participant group will be excluded, 
including taking medications that influence pain perception (e.g. analgesics, non-
steroidals, antidepressants). The number of HC subjects to be tested has to be 
determined during the course of the study, as reference data have to be obtained from at 
least 8 male and 8 female HC subjects [4] for each maximal pain area nominated by the 
symptomatic participants. The minimum number of 8 is based on recommendations of 
the DNFS and their published methodology [4]. Participants with either L5 or S1 
radicular pain will be included in the study, hence it is anticipated that 4 body regions 
may be nominated as maximal pain area (thigh L5 and S1 distribution, lower leg L5 and 
S1 distribution).  
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Testing protocol 
The initial patient assessment will take approximately 2.5 hours. The participant’s pain 
history, including pain distribution and pain behaviour will be recorded and a clinical 
examination for determination of neurological deficits will be conducted (reflex, strength 
and sensation testing). 
 
The following measurements will be taken either in interview format or via 
questionnaires. Finally QST will be performed.  
 
• Duration of pain (part of Örebro Musculoskeletal Screening Questionnaire (Short 
form) [18] 
• Pain intensity of back and leg pain (11- point numerical rating scale (NRS)  
• Health care utilisation  
• Bothersomeness of back and leg pain  
• Confidence in recovery (‘great deal’, ‘moderate’, ‘no confidence’, ‘do not know’) 
[37]  
• Intake of medication  
• Sleep quality (Visual Analogue Scale) [52] 
• Duration of inability to work   
• Functional status (Oswestry Disability Index) [14] 
• Anxiety and Depression (Hospital Anxiety and Depression Scale) (HADS) [23] 
• Pain descriptors (painDETECT) [15] 
• Fear avoidance behaviour (Tampa Scale for Kinesiophobia) [51] 
• Pain catastrophizing (Pain catastrophizing Scale) [50] 
• Health-related quality of life (Short form-36 health questionnaire) (SF-36v2®) [55] 
• Risk assessment for persistent pain (Örebro Musculoskeletal Screening 
Questionnaire) (Short form) [18] 
 
The degree of nerve root compression [39] will be determined by a neurosurgery 
registrar who is blind to the participant’s enrolment into the study. 
HC participants will complete the HADs and SF 36 questionnaire and their sleep quality 
will be determined. 
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Quantitative sensory testing 
Standardized QST will be performed according to the QST protocol of DFNS [41; 42]. 
The protocol includes the following assessments: cold and warm detection thresholds, 
;he number of paradoxical heat sensations during the procedure of alternating warm and 
cold stimuli; cold and heat pain thresholds; mechanical detection threshold; mechanical 
pain threshold; stimulus-response functions: mechanical pain sensitivity and dynamic 
mechanical allodynia; wind-up ratio; vibration detection threshold and pressure pain 
threshold.  
 
QST measurements will be taken from the main pain area nominated by the 
symptomatic participant, as required for the assessment of neuropathic pain [21] and the 
contralateral side [21] and from the ipsilateral hand dorsum as a remote control site, plus 
thermal and mechanical detection thresholds will be assessed in the relevant 
dermatome (L5, S1) on the symptomatic side. Testing sites in HC subjects will be 
matched to the sites tested in symptomatic participant. Testing of the full QST protocol 
will take approximately 30 minutes per test area. Testing of dermatomal detection 
thresholds will take less than 10 minutes.  
 
 
Outcome assessment 3 months postoperatively 
• Functional status Oswestry [14] 
• Pain intensity  
• Pain descriptors  [15] 
• Health-related quality of life [55] 
• Return to work (yes/no)  
• Health care utilisation   
• Medication intake  
• Patient Global Impression of Change Scale [12]  
• Bothersomenes of back and leg pain  
• QST in previously tested maximal pain area and dermatome (appr. 40 minutes) 
The assessment will take approximately one hour. 
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Outcome assessment 1 year postoperatively:  
The same questionnaires as at 3 months will be mailed to the participants. 
 
Statistical analysis 
QST data will be log-transformed prior to statistical analysis except those data which are 
normally distributed as raw data [42]. To compare and illustrate participants’ QST data 
profiles with the group mean of age/gender matched healthy controls particpants’ data 
will be z-transformed for each single parameter by using the following expression: Z-
score = (Mean single proband – Mean healthy controls)/SD healthy controls [42]. Z-values will be 
calculated based on the HC group data.  
 
Differences of z-score QST data between the symptomatic participant group and HC and 
tested body regions will be compared using a two-way analysis of covariance (ANCOVA) 
with tested body areas (maximal pain area, hand) as the within-subjects factor. Group 
(participants/controls) will be entered as between-subjects factors. Anxiety, depression 
and fear avoidance scores will be entered as covariates to account for potential 
influence of these factors on pain responses [40]. Depending on data distribution, 
differences of some predictor variables (Oswestry Disability Index [14], HADS 
[23],Tampa Scale for Kinesiophobia [51], SF-36v2® [55]) between patients and HC will 
be compared using parametric (t-Test)  or non-parametric tests (Mann-Whitney-U test). 
 
Differences in outcome measures pre- and post-surgery will be compared using 
repeated measures ANOVA in case of normal distribution of variables, and the 
Friedman’s Test for non-normal distributed data. Multivariate regression analyses will be 
performed to assess associations between the predictor variables, QST measures and 
the outcome variables.  
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